Location: Burlington, VT
CIK: 0001618205 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $101M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 323,358 | $14.97M | 14.9% | $46.29 | $44.70 | +5.6% | COM | 110122108 |
| KLAC | KLA CORPORATION | 15,848 | $14.2M | 14.1% | $895.74 * | $748.55 | 0.0% | COM NEW | 482480100 |
| CORT | CORCEPT THERAPEUTICS INC | 67,200 | $4.932M | 4.9% | $73.40 | $14.57 | +397.7% | COM | 218352102 |
| OVV | OVINTIV INC | 107,500 | $4.09M | 4.1% | $38.05 * | $35.12 | +4.5% | COM | 69047Q102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 187,800 | $4.051M | 4.0% | $21.57 * | $27.98 | -33.6% | COM | 004225108 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 30,940 | $3.889M | 3.9% | $125.69 * | $73.35 | +56.3% | COM | 64125C109 |
| PHR | PHREESIA INC | 114,700 | $3.264M | 3.2% | $28.46 * | $21.44 | +18.4% | COM | 71944F106 |
| PRTA | PROTHENA CORP PLC | 451,019 | $2.738M | 2.7% | $6.07 * | $23.68 | -68.3% | SHS | G72800108 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 48,000 | $2.653M | 2.6% | $55.27 * | $33.79 | +42.0% | COM | 74366E102 |
| STOK | STOKE THERAPEUTICS INC | 210,000 | $2.384M | 2.4% | $11.35 * | $7.86 | +20.9% | COM | 86150R107 |
| ELUT | ELUTIA INC | 1,159,059 | $2.295M | 2.3% | $1.98 | $5.84 | -65.4% | COM | 05479K106 |
| CSTL | CASTLE BIOSCIENCES INC | 110,600 | $2.258M | 2.2% | $20.42 * | $23.48 | -21.2% | COM | 14843C105 |
| — | QUIDELORTHO CORP | 72,548 | $2.091M | 2.1% | $28.82 | $65.09 | — | COM | 74838J101 |
| EQT | EQT CORPORATION | 34,619 | $2.019M | 2.0% | $58.32 * | $33.40 | +60.4% | COM | 26884L109 |
| HROW | HARROW HEALTH INC | 60,000 | $1.832M | 1.8% | $30.54 * | $6.05 | +344.5% | COM | 415858109 |
| NVCR | NOVOCURE LTD | 101,000 | $1.798M | 1.8% | $17.80 * | $17.86 | -2.5% | ORD SHS | G6674U108 |
| AXGN | AXOGEN INC | 161,000 | $1.747M | 1.7% | $10.85 * | $7.40 | +77.0% | COM | 05463X106 |
| — | BIODESIX INC | 5,736,113 | $1.619M | 1.6% | $0.28 | $5.56 | — | COM | 09075X108 |
| TVTX | TRAVERE THERAPEUTICS INC | 103,000 | $1.524M | 1.5% | $14.80 * | $13.34 | +24.2% | COM | 89422G107 |
| FHTX | FOGHORN THERAPEUTICS INC | 310,930 | $1.461M | 1.5% | $4.70 * | $16.56 | -74.8% | COM | 344174107 |
| ALKS | ALKERMES PLC | 50,000 | $1.431M | 1.4% | $28.61 * | $21.00 | +41.7% | SHS | G01767105 |
| MASI | MASIMO CORP | 8,280 | $1.393M | 1.4% | $168.22 * | $81.54 | +95.9% | COM | 574795100 |
| QURE | UNIQURE NV | 98,697 | $1.376M | 1.4% | $13.94 * | $12.44 | +8.1% | SHS | N90064101 |
| UTHR | UNITED THERAPEUTICS CORP | 4,250 | $1.221M | 1.2% | $287.35 * | $93.09 | +221.1% | COM | 91307C102 |
| DCGO | DOCGO INC | 764,062 | $1.2M | 1.2% | $1.57 * | $4.44 | -58.1% | COM | 256086109 |
| TMCI | TREACE MEDICAL CONCEPTS INC | 176,947 | $1.04M | 1.0% | $5.88 * | $6.62 | -1.6% | COM | 89455T109 |
| SLDB | SOLID BIOSCIENCES INC | 178,768 | $871K | 0.9% | $4.87 * | $4.07 | -13.2% | COM NEW | 83422E204 |
| — | KINIKSA PHARMACEUTICALS LTD | 30,000 | $830K | 0.8% | $27.67 | $13.10 | — | COM | G5269C101 |
| FCX | FREEPORT-MCMORAN CL-B | 18,033 | $782K | 0.8% | $43.35 * | $37.70 | 0.0% | CL-B | 35671D857 |
| KALV | KALVISTA PHARMACEUTICALS INC | 67,000 | $757K | 0.8% | $11.30 * | $15.61 | -21.7% | COM | 483497103 |
| GPCR | STRUCTURE THERAPEUTICS INC | 36,000 | $747K | 0.7% | $20.74 | $20.74 | — | SPONS ADR | 86366E106 |
| APGE | APOGEE THERAPEUTICS INC | 16,000 | $695K | 0.7% | $43.43 * | $38.35 | -0.8% | COM | 03770N101 |
| — | OUTSET MEDICAL INC | 34,584 | $664K | 0.7% | $19.21 | $6.40 | — | COM | 690145107 |
| XENE | XENON PHARMACEUTICALS INC | 21,000 | $657K | 0.7% | $31.30 * | $34.29 | -4.9% | COM | 98420N105 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 18,000 | $654K | 0.6% | $36.36 | $48.11 | -25.1% | COM | 90400D108 |
| AXSM | AXSOME THERAPEUTICS INC | 6,000 | $626K | 0.6% | $104.39 | $93.93 | +12.7% | COM | 05464T104 |
| OLMA | OLEMA PHARMACEUTICALS INC | 134,000 | $571K | 0.6% | $4.26 * | $4.46 | 0.0% | COM | 68062P106 |
| SRRK | SCHOLAR ROCK HOLDING CORP | 16,000 | $567K | 0.6% | $35.42 * | $35.52 | -11.6% | COM | 80706P103 |
| NTLA | INTELLIA THERAPEUTICS INC | 60,000 | $563K | 0.6% | $9.38 * | $8.21 | 0.0% | COM | 45826J105 |
| KIDS | ORTHOPEDIATRICS CORP | 26,000 | $558K | 0.6% | $21.48 | $23.99 | -9.9% | COM | 68752L100 |
| IMNM | IMMUNOME INC | 60,000 | $558K | 0.6% | $9.30 * | $8.20 | 0.0% | COM | 45257U108 |
| XNCR | XENCOR INC | 70,000 | $550K | 0.5% | $7.86 * | $12.91 | -30.5% | COM | 98401F105 |
| HALO | HALOZYME THERAPEUTICS INC | 10,000 | $520K | 0.5% | $52.02 * | $51.20 | +11.1% | COM | 40637H109 |
| PACB | PACIFIC BIOSCIENCES CALIF INC | 400,000 | $496K | 0.5% | $1.24 * | $1.15 | 0.0% | COM | 69404D108 |
| INBX | INHIBRX BIOSCIENCES INC | 32,110 | $458K | 0.5% | $14.27 * | $14.64 | -11.7% | COM | 45720N103 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 8,000 | $378K | 0.4% | $47.20 * | $47.07 | -13.5% | CLASS A ORD | 61559X104 |
| ATEC | ALPHATEC HOLDINGS INC | 33,000 | $366K | 0.4% | $11.10 * | $8.72 | +31.7% | COM | 02081G201 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 40,000 | $358K | 0.4% | $8.96 * | $5.77 | +61.5% | COM | 09058V103 |
| — | BLUEPRINT MEDICINES CORP | 2,700 | $346K | 0.3% | $128.18 | $92.50 | — | COM | 09627Y109 |
| CYTK | CYTOKINETICS INC | 10,000 | $330K | 0.3% | $33.04 * | $27.06 | +28.6% | COM | 23282W605 |
| CADL | CANDEL THERAPEUTICS INC | 60,000 | $304K | 0.3% | $5.06 | $5.91 | -12.9% | COM | 137404109 |
| TELA | TELA BIO INC | 155,000 | $301K | 0.3% | $1.94 * | $2.74 | -52.3% | COM | 872381108 |
| COGT | COGENT BIOSCIENCES INC | 40,000 | $287K | 0.3% | $7.18 * | $5.54 | 0.0% | COM | 19240Q201 |
| WVE | WAVE LIFE SCIENCES LTD | 40,300 | $262K | 0.3% | $6.50 | $5.34 | +23.6% | SHS | Y95308105 |
| TXG | 10X GENOMICS INC | 22,000 | $255K | 0.3% | $11.58 * | $32.21 | -71.7% | CL A COM | 88025U109 |
| APLS | APELLIS PHARMACEUTICALS INC | 14,000 | $242K | 0.2% | $17.31 * | $39.43 | -53.1% | COM | 03753U106 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 25,000 | $240K | 0.2% | $9.59 * | $5.53 | 0.0% | COM | 71722W107 |
| BBIO | BRIDGEBIO PHARMA INC | 5,000 | $216K | 0.2% | $43.18 * | $36.37 | 0.0% | COM | 10806X102 |
| NPCE | NEUROPACE INC | 16,442 | $183K | 0.2% | $11.14 * | $10.19 | +22.7% | COM | 641288105 |
| GOSS | GOSSAMER BIO INC | 138,176 | $170K | 0.2% | $1.23 * | $5.35 | -79.6% | COM | 38341P102 |
| FOLD | AMICUS THERAPEUTICS INC | 28,000 | $160K | 0.2% | $5.73 * | $14.56 | -55.7% | COM | 03152W109 |
| ZBIO | ZENAS BIOPHARMA INC | 16,500 | $160K | 0.2% | $9.69 | $15.60 | -37.6% | COM | 98937L105 |
| CGEM | CULLINAN THERAPEUTICS INC | 20,000 | $151K | 0.1% | $7.53 * | $40.60 | -80.2% | COM | 230031106 |
| — | KARYOPHARM THERAPEUTICS INC | 27,985 | $121K | 0.1% | $4.31 | $7.66 | — | COM | 48576U106 |
| — | APPLIED THERAPEUTICS INC | 280,000 | $87,108 | 0.1% | $0.31 | $0.31 | — | COM | 03828A101 |
| VTYX | VENTYX BIOSCIENCES INC | 28,800 | $61,632 | 0.1% | $2.14 * | $21.31 | -92.4% | COM | 92332V107 |
| IFRX | INFLARX NV | 50,000 | $39,500 | 0.0% | $0.79 * | $3.70 | -68.1% | COM | N44821101 |
| — | APTEVO THERAPEUTICS INC | 10,000 | $30,500 | 0.0% | $3.05 | $3.05 | — | COM NEW | 03835L405 |
| ALMS | ALUMIS INC | 10,000 | $30,000 | 0.0% | $3.00 * | $12.13 | -61.1% | COM | 022307102 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 17,000 | $19,720 | 0.0% | $1.16 * | $13.92 | -90.5% | COM | 98943L107 |
| — | ACCELERATE DIAGNOSTICS INC | 325,239 | $2,082 | 0.0% | $0.01 | $13.66 | — | COM | 00430H102 |